Cite Filings / STLN / 0001104659-25-038121

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Starling Oncology, Inc. Filed 2025-04-23 Acc 0001104659-25-038121

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-09-05 SCHEDULE 13D/A Beneficial Ownership Report
2025-04-28 4/A Director bought 45,280 shares at $1.04 ($47,168)
2025-04-23 SCHEDULE 13D/A Beneficial Ownership Report
2025-03-28 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…